1. Endostatin gene therapy inhibits intratumoral macrophage M2 polarization
    Karen Foguer et al, 2016, Biomedicine & Pharmacotherapy CrossRef
  2. The Role of the Immune System in the Effects of Cancer on Bone
    Rebecca Silbermann et al, 2016, Osteoimmunology CrossRef
  3. Mechanisms of immune evasion and current status of checkpoint inhibitors in non‐small cell lung cancer
    Angel Qin et al, 2016, Cancer Medicine CrossRef
  4. LAP TGF-Beta Subset of CD4+CD25+CD127−Treg Cells is Increased and Overexpresses LAP TGF-Beta in Lung Adenocarcinoma Patients
    Lorenzo Islas-Vazquez et al, 2015, BioMed Research International CrossRef
  5. Ectonucleotidase CD39 and Checkpoint Signalling Receptor Programmed Death 1 are Highly Elevated in Intratumoral Immune Cells in Non–small-cell Lung Cancer
    Anders Tøndell et al, 2020, Translational Oncology CrossRef
  6. Effect of TGF‑β1 on blood CD4+CD25high regulatory T cell proliferation and Foxp3 expression during non‑small cell lung cancer blood metastasis
    Yi Hu et al, 2018, Experimental and Therapeutic Medicine CrossRef
  7. Clinical significance of the frequency of regulatory T cells in regional lymph node lymphocytes as a prognostic factor for non-small-cell lung cancer
    Takeshi Hanagiri et al, 2013, Lung Cancer CrossRef
  8. Tumor-infiltrating lymphocyte therapy for lung cancer and its future paradigms
    Ali Nowroozi et al, 2022, Expert Opinion on Biological Therapy CrossRef
  9. Elevated regulatory T cells, surface and intracellular CTLA-4 expression and interleukin-17 in the lung cancer microenvironment in humans
    Iwona Kwiecien et al, 2017, Cancer Immunology, Immunotherapy CrossRef
  10. Overcoming microenvironmental resistance to PD-1 blockade in genetically engineered lung cancer models
    Amaia Martinez-Usatorre et al, 2021, Science Translational Medicine CrossRef
  11. CD4+/CD25 high /FoxP3+/CD127− regulatory T cells in bronchoalveolar lavage fluid of lung cancer patients
    Iwona Osińska et al, 2016, Human Immunology CrossRef
  12. Human lung tumor FOXP+ Tregs upregulate four “Treg-locking” transcription factors
    Tatiana Akimova et al, 2017, JCI Insight CrossRef
  13. Elevated Foxp3/CD8 Ratio in Lung Adenocarcinoma Metastatic Lymph Nodes Resected by Transcervical Extended Mediastinal Lymphadenectomy
    Joanna Domagala-Kulawik et al, 2017, BioMed Research International CrossRef
  14. NK cell-based therapeutics for lung cancer
    A. Graham Pockley et al, 2020, Expert Opinion on Biological Therapy CrossRef
  15. Flow cytometric analysis of the graft‐versus‐Leukemia‐Effect After Hematopoietic Stem Cell Transplantation in Mice
    Felix Schmidt et al, 2015, Cytometry Part A CrossRef
  16. Interaction between Treg cells and tumor-associated macrophages in the tumor microenvironment of epithelial ovarian cancer
    Qinyi Zhu et al, 2016, Oncology Reports CrossRef
  17. PD-1 blockade attenuates surgery-mediated immunosuppression and boosts Th1 immunity perioperatively in oesophagogastric junctional adenocarcinoma
    Maria Davern et al, 2023, Frontiers in Immunology CrossRef
  18. Absence of Immune Response as a Sign of Tissue Tolerance in Small-Cell Lung Cancer
    Antonio Manenti et al, 2014, Gene, Cell and Tissue CrossRef
  19. FOXP3+ Treg as a therapeutic target for promoting anti-tumor immunity
    Theresa L. Whiteside, 2018, Expert Opinion on Therapeutic Targets CrossRef